Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Pedersen`s Laboratorium ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.1% 2.1%   Bankruptcy risk   1.7% 0.8% 0.7% 0.6% 0.6% 0.6% 6.8% 6.6%   Credit score (0-100)   74 92 93 96 97 97 35 36   Credit rating   A AA AA AA AA AA BBB BBB   Credit limit (kDKK)   9.9 1,021.9 1,340.2 1,514.5 1,645.9 1,828.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,684 2,618 4,141 3,920 5,560 5,095 0.0 0.0   EBITDA   148 872 1,942 1,593 2,404 2,610 0.0 0.0   EBIT   -436 277 1,475 1,050 1,728 1,820 0.0 0.0   Pre-tax profit (PTP)   -437.0 264.0 1,409.5 956.1 1,605.1 1,713.6 0.0 0.0   Net earnings   -437.9 561.3 1,098.7 786.4 1,335.2 1,356.8 0.0 0.0   Pre-tax profit without non-rec. items   -437 264 1,410 956 1,605 1,714 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   10,513 10,801 10,841 11,460 14,651 14,940 0.0 0.0   Shareholders equity total   10,990 11,551 12,650 13,436 14,772 16,128 16,028 16,028   Interest-bearing liabilities   2.8 1,526 1,881 2,005 2,981 2,263 0.0 0.0   Balance sheet total (assets)   12,536 14,649 17,403 17,689 20,321 21,447 16,028 16,028   Net Debt   -360 534 -185 -285 2,192 484 -16,028 -16,028     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,684 2,618 4,141 3,920 5,560 5,095 0.0 0.0   Gross profit growth   5.5% 55.5% 58.2% -5.3% 41.9% -8.4% -100.0% 0.0%   Employees   3 4 4 6 8 7 0 0   Employee growth %   0.0% 33.3% 0.0% 50.0% 33.3% -12.5% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   12,536 14,649 17,403 17,689 20,321 21,447 16,028 16,028   Balance sheet change%   -2.7% 16.9% 18.8% 1.6% 14.9% 5.5% -25.3% 0.0%   Added value   147.5 872.0 1,942.4 1,593.1 2,270.9 2,609.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -899 -307 -427 75 2,515 -501 -14,940 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -3.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -25.9% 10.6% 35.6% 26.8% 31.1% 35.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -3.4% 2.0% 9.2% 6.0% 9.1% 8.8% 0.0% 0.0%   ROI %   -3.5% 2.1% 9.9% 6.4% 9.6% 9.3% 0.0% 0.0%   ROE %   -3.9% 5.0% 9.1% 6.0% 9.5% 8.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   87.7% 78.9% 72.7% 76.0% 72.7% 75.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -243.7% 61.2% -9.5% -17.9% 91.2% 18.5% 0.0% 0.0%   Gearing %   0.0% 13.2% 14.9% 14.9% 20.2% 14.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   62.2% 1.7% 3.8% 4.8% 4.9% 4.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.2 1.1 1.4 1.4 0.9 1.2 0.0 0.0   Current Ratio   4.8 1.8 1.9 2.1 1.4 1.8 0.0 0.0   Cash and cash equivalent   362.3 991.8 2,066.0 2,290.7 788.8 1,778.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,604.2 1,652.0 3,106.5 3,300.5 1,714.4 2,945.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   49 218 486 266 284 373 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   49 218 486 266 301 373 0 0   EBIT / employee   -145 69 369 175 216 260 0 0   Net earnings / employee   -146 140 275 131 167 194 0 0